Summary

The Middle East & Africa vascular closure device market was valued at US$ 78.28 million in 2022 and is expected to reach US$ 129.04 million by 2030; it is estimated to record a CAGR of 6.4% from 2022 to 2030.

Burgeoning Demand for Minimally Invasive Devices Drives Middle East & Africa Vascular Closure Device Market

Improvements in medical science and technologies have given way to minimally invasive devices, which can aid in the replacement of traditional painful surgical methods by minimally invasive or noninvasive methods. Minimally invasive techniques have gained popularity in surgical fields such as cardiac surgery. Many of these procedures are performed using femoral cannulation for extracorporeal circulation. Vascular closure devices have gained popularity as they reduce the invasiveness and supersede surgical cut-down to cannulate the femoral artery. Vascular closure devices are mainly used in transcatheter and endovascular interventions to enable wound healing and reduce procedure time. Angiography is one of the common procedures performed in a wide variety of specialties, including vascular surgery, interventional radiology, and diagnostic and interventional cardiology. Vascular closure devices are useful in the settings of a large body habitus, anticoagulation, and antiplatelet therapies. They are also used in cases where extended bed rest may not be desirable (such as a patient with extensive pressure ulcers). A vascular closure device with resorbable collagen material, which eliminates the use of suture materials, has been introduced for transfemoral transcatheter aortic valve implantation (TAVI). For instance, the MANTA device by Teleflex Medical Inc. is adequate for the closure of arterial access sites of up to 25 Fr. Safety and efficacy of the system were demonstrated in a real-world TAVI patient cohort. Thus, the increasing demand for minimally invasive devices drives the vascular closure devices market growth.

Middle East & Africa Vascular Closure Device Market Overview

Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya are among the major countries in the Rest of the Middle East & Africa. Growing healthcare spending for better healthcare services is a significant factor contributing to the vascular closure devices market growth in the Rest of the Middle East & Africa. According to the World Bank Group, the healthcare expenditure of Kuwait and Israel is 6.31% and 8.32% of their GDP, respectively. These countries have been focusing on developing their medical device industry. Further, the high prevalence of cardiovascular diseases such as coronary artery disease and cardiac disorders in countries such as Israel, Egypt, and Lebanon propel the demand for surgical procedures. Thus, the high prevalence of cardiovascular disease and significant healthcare expenditure are the notable factors fueling the demand for minimally invasive surgical devices in the Rest of the Middle East & Africa, eventually propelling the vascular closure devices market growth.

Middle East & Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Vascular Closure Device Market Segmentation

The Middle East & Africa vascular closure device market is segmented based on product type, access, procedure, end user, and country.

Based on product type, the Middle East & Africa vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.

By access, the Middle East & Africa vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.

By procedure, the Middle East & Africa vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.

In terms of end use, the Middle East & Africa vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.

Based on country, the Middle East & Africa vascular closure device market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa vascular closure device market in 2022.

Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, Haemonetics Corp, Medtronic Plc, and Teleflex Inc are some of the leading companies operating in the Middle East & Africa vascular closure device market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Vascular Closure Device Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Cardiovascular Diseases
4.1.2 Burgeoning Demand for Minimally Invasive Devices
4.2 Market Restraints
4.2.1 Risk of Infection Related to Vascular Closure Devices
4.3 Market Opportunities
4.3.1 Untapped Potential of Emerging Economies
4.4 Future Trends
4.4.1 Strategic Activities by Manufacturers
4.5 Impact Analysis:
5. Vascular Closure Device Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Vascular Closure Device Market Revenue (US$ Mn), 2022 - 2030
6. Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 - by Product Type
6.1 Overview
6.2 Middle East & Africa Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
6.3 Active Approximators
6.3.1 Overview
6.3.2 Active Approximators: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Active Approximators: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Passive Approximators
6.4.1 Overview
6.4.2 Passive Approximators: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Passive Approximators: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
6.5 External Hemostatic Devices
6.5.1 Overview
6.5.2 External Hemostatic Devices: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 - by Access
7.1 Overview
7.2 Middle East & Africa Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
7.3 Femoral Access
7.3.1 Overview
7.3.2 Femoral Access: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Radial Access
7.4.1 Overview
7.4.2 Radial Access: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 - by Procedure
8.1 Overview
8.2 Middle East & Africa Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
8.3 Interventional Cardiology
8.3.1 Overview
8.3.2 Interventional Cardiology: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Interventional Radiology
8.4.1 Overview
8.4.2 Interventional Radiology: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Endovascular Surgical
8.5.1 Overview
8.5.2 Endovascular Surgical: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 - by End Users
9.1 Overview
9.2 Middle East & Africa Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Center
9.4.1 Overview
9.4.2 Ambulatory Surgical Center: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Middle East & Africa Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Vascular Closure Device Market - Country Analysis
10.1.1.1 Middle East & Africa Vascular Closure Device Market by Country
10.1.1.2 UAE
10.1.1.2.1 Overview
10.1.1.2.2 UAE: Middle East & Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 UAE: Middle East & Africa Vascular Closure Device Market, by Product Type
10.1.1.2.3.1 UAE: Middle East & Africa Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.2.3.2 UAE: Middle East & Africa Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.2.4 UAE: Middle East & Africa Vascular Closure Device Market, by Access
10.1.1.2.5 UAE: Middle East & Africa Vascular Closure Device Market, by Procedure
10.1.1.2.6 UAE: Middle East & Africa Vascular Closure Device Market, by End Users
10.1.1.3 Saudi Arabia
10.1.1.3.1 Overview
10.1.1.3.2 Saudi Arabia: Middle East & Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Saudi Arabia: Middle East & Africa Vascular Closure Device Market, by Product Type
10.1.1.3.3.1 Saudi Arabia: Middle East & Africa Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.3.3.2 Saudi Arabia: Middle East & Africa Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.3.4 Saudi Arabia: Middle East & Africa Vascular Closure Device Market, by Access
10.1.1.3.5 Saudi Arabia: Middle East & Africa Vascular Closure Device Market, by Procedure
10.1.1.3.6 Saudi Arabia: Middle East & Africa Vascular Closure Device Market, by End Users
10.1.1.4 South Africa
10.1.1.4.1 Overview
10.1.1.4.2 South Africa: Middle East & Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 South Africa: Middle East & Africa Vascular Closure Device Market, by Product Type
10.1.1.4.3.1 South Africa: Middle East & Africa Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.4.3.2 South Africa: Middle East & Africa Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.4.4 South Africa: Middle East & Africa Vascular Closure Device Market, by Access
10.1.1.4.5 South Africa: Middle East & Africa Vascular Closure Device Market, by Procedure
10.1.1.4.6 South Africa: Middle East & Africa Vascular Closure Device Market, by End Users
10.1.1.5 Rest of Middle East & Africa
10.1.1.5.1 Overview
10.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Vascular Closure Device Market, by Product Type
10.1.1.5.3.1 Rest of Middle East & Africa: Middle East & Africa Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.5.3.2 Rest of Middle East & Africa: Middle East & Africa Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Vascular Closure Device Market, by Access
10.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Vascular Closure Device Market, by Procedure
10.1.1.5.6 Rest of Middle East & Africa: Middle East & Africa Vascular Closure Device Market, by End Users
11. Vascular Closure Device Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Vascular Closure Devices Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Cordis Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Haemonetics Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Abbott Laboratories
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Becton Dickinson and Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Cardinal Health Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medtronic Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Teleflex Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms